Showing results (11-20 of 378) with videos related to

Sort By:
Pageof 38
Laboratory Investigation; a Journal of Technical Methods and Pathology|April 1, 1991
Recombinant human interleukin 3 induces proliferation of inflammatory cells and keratinocytes in vivoB Volc-Platzer, P Valent, T Radaszkiewicz, et al.
Leukemia|March 1, 1988
T cell receptor alpha mRNA transcription in T-lymphoblastic transformation of chronic myelocytic leukemiaP Valent, C R Bartram, T Radaszkiewicz, et al.
Blood|June 15, 1990
Recombinant human interleukin-3 expands the pool of circulating hematopoietic progenitor cells in primates--synergism with recombinant human granulocyte/macrophage colony-stimulating factorK Geissler, P Valent, P Mayer, et al.
Blood|July 15, 1991
Interleukin-4 counteracts pyrogen-induced downregulation of thrombomodulin in cultured human vascular endothelial cellsS Kapiotis, J Besemer, D Bevec, et al.
Blood|August 1, 1992
Type beta transforming growth factors promote interleukin-3 (IL-3)-dependent differentiation of human basophils but inhibit IL-3-dependent differentiation of human eosinophilsC Sillaber, K Geissler, R Scherrer, et al.
Blood|May 15, 1989
Mast cell typing: demonstration of a distinct hematopoietic cell type and evidence for immunophenotypic relationship to mononuclear phagocytesP Valent, L K Ashman, W Hinterberger, et al.
Blood|November 1, 1990
Human basophils express interleukin-4 receptorsP Valent, J Besemer, K Kishi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 15, 1990
IL-3 promotes basophilic differentiation of KU812 cells through high affinity binding sitesP Valent, J Besemer, K Kishi, et al.
The Journal of Biological Chemistry|June 25, 1992
Characterization of prostaglandin (PG)-binding sites expressed on human basophils. Evidence for a prostaglandin E1, I2, and a D2 receptorI Virgolini, S Li, C Sillaber, et al.
Medical and Pediatric Oncology. Supplement|January 1, 1992
Treatment of de novo acute myelogenous leukemia with recombinant granulocyte macrophage-colony-stimulating factor in combination with standard induction chemotherapy: effect of granulocyte macrophage-colony-stimulating factor on white blood cell countsP Valent, C Sillaber, K Geissler, et al.
Pageof 38